Abbott, AbbVie Must Produce Adverse Event Reports For AndroGel Testosterone
CHICAGO — The Illinois federal judge overseeing the testosterone multidistrict litigation on June 22 granted a plaintiffs’ motion compelling defendants Abbott Laboratories and AbbVie Inc. to produce full drug safety and...To view the full article, register now.
Already a subscriber? Click here to view full article